» Articles » PMID: 21996313

Type I Interferon Response to Extracellular Bacteria in the Airway Epithelium

Overview
Journal Trends Immunol
Date 2011 Oct 15
PMID 21996313
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The airway epithelium possesses many mechanisms to prevent bacterial infection. Not only does it provide a physical barrier, but it also acts as an extension of the immune system through the expression of innate immune receptors and corresponding effectors. One outcome of innate signaling by the epithelium is the production of type I interferons (IFNs), which have traditionally been associated with activation via viral and intracellular organisms. We discuss how three extracellular bacterial pathogens of the airway activate this intracellular signaling cascade through both surface components as well as via secretion systems, and the differing effects of type I IFN signaling on host defense of the respiratory tract.

Citing Articles

Multiple mechanisms enable broad-spectrum activity of the root extract EPs 7630 against acute respiratory tract infections.

Cinatl Jr J, Wass M, Michaelis M Front Pharmacol. 2024; 15:1455870.

PMID: 39469622 PMC: 11513585. DOI: 10.3389/fphar.2024.1455870.


Type 1 interferons promote Staphylococcus aureus nasal colonization by inducing phagocyte apoptosis.

Vozza E, Kelly A, Daly C, ORourke S, Carlile S, Morris B Cell Death Discov. 2024; 10(1):403.

PMID: 39271670 PMC: 11399434. DOI: 10.1038/s41420-024-02173-2.


The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation.

Frey A, Lunding L, Wegmann M Cells. 2023; 12(18).

PMID: 37759430 PMC: 10526792. DOI: 10.3390/cells12182208.


Modulation of innate immunity in airway epithelium for host-directed therapy.

Myszor I, Gudmundsson G Front Immunol. 2023; 14:1197908.

PMID: 37251385 PMC: 10213533. DOI: 10.3389/fimmu.2023.1197908.


Pseudomonas aeruginosa Induces Interferon-β Production to Promote Intracellular Survival.

Yang L, Zhang Y, Liu Y, Xie Y, Weng D, Ge B Microbiol Spectr. 2022; 10(5):e0155022.

PMID: 36190409 PMC: 9603546. DOI: 10.1128/spectrum.01550-22.


References
1.
Benveniste E, Qin H . Type I interferons as anti-inflammatory mediators. Sci STKE. 2007; 2007(416):pe70. DOI: 10.1126/stke.4162007pe70. View

2.
Faure K, Sawa T, Ajayi T, Fujimoto J, Moriyama K, Shime N . TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir Res. 2004; 5:1. PMC: 389879. DOI: 10.1186/1465-9921-5-1. View

3.
Berube J, Bourdon C, Yao Y, Rousseau S . Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells. Cell Signal. 2009; 21(3):448-56. DOI: 10.1016/j.cellsig.2008.12.001. View

4.
Martin F, Gomez M, Wetzel D, Memmi G, OSeaghdha M, Soong G . Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest. 2009; 119(7):1931-9. PMC: 2701857. DOI: 10.1172/jci35879. View

5.
Debes G, Dahl M, Mahiny A, Bonhagen K, Campbell D, Siegmund K . Chemotactic responses of IL-4-, IL-10-, and IFN-gamma-producing CD4+ T cells depend on tissue origin and microbial stimulus. J Immunol. 2005; 176(1):557-66. DOI: 10.4049/jimmunol.176.1.557. View